[DOI] [Google Scholar] Laity J
As a highly selective GLP-1 receptor agonist, Semaglutide is designed to mimic the action of endogenous metabolic signaling hormones
New England Journal of Medicine 358 (14): 14541464
Exposure to 40C or above can destroy the peptide within hours
This peptide also appeared to modulate immune cell behavior, with reports of increased macrophage activity, which may support resolution rather than persistence of inflammation
The following types are those most commonly reported: Central Nervous System CNS manifestations are excitatory and/or depressant and may be characterized by lightheadedness, nervousness, apprehension, euphoria, confusion, dizziness, drowsiness, tinnitus, blurred or double vision, vomiting, sensations of heat, cold or numbness, twitching, tremors, convulsions, unconsciousness, respiratory depression and arrest